Sentence: Azacitidine and enasidenib are two therapies available for treatment of acute myelogenous leukemia ( AML ) , and the mechanisms of action of these drugs involve alteration of aberrant DNA methylation .
Drug combination annotation:
[{'class': 'COMB', 'spans': ['Azacitidine', 'enasidenib'], 'is_context_needed': True}]